Immunotherapy for the treatment of biliary tract cancer: an evolving landscape
Biliary tract cancers (BTCs), consisting of intrahepatic and extrahepatic cholangiocarcinoma and gallbladder cancer, are an aggressive, heterogeneous malignancy. They are most often diagnosed in the locally advanced or metastatic setting, at which point treatment consists of systemic therapy or best...
Main Authors: | Helen Catherine Wilbur, Nilofer S. Azad |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2024-03-01
|
Series: | Therapeutic Advances in Medical Oncology |
Online Access: | https://doi.org/10.1177/17588359241235799 |
Similar Items
-
Evolving Role of Immunotherapy in Advanced Biliary Tract Cancers
by: Sandra Kang, et al.
Published: (2022-03-01) -
Advances in immunotherapy for biliary tract cancers
by: Yuhao Zhao, et al.
Published: (2024-03-01) -
Immunotherapy in Advanced Biliary Tract Cancers
by: Alice Boilève, et al.
Published: (2021-03-01) -
Targeted Therapies in Advanced Biliary Tract Cancer: An Evolving Paradigm
by: Sakti Chakrabarti, et al.
Published: (2020-07-01) -
The evolving landscape of immunotherapy for the treatment of allergic conditions
by: Aarti Pandya, et al.
Published: (2023-08-01)